This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For example, data from the National Institute on Drug Abuse reveal that the level of THC in cannabis samples seized by law enforcement averaged 4% in 1995. By contrast, in 2022, the average level of THC was upwards of 16%. By now, it is a common refrain: the weed is getting stronger. Recent research backs this up.
As of July 2022, 38 states in America have legalized medical cannabis, and 19 states and the District of Columbia have established recreational cannabis programs. Research from New Frontier Data estimates that around 3 million people grow their own cannabis at home in the United States. Cultivation Costs for Homegrowers.
The study is now open for registration and the deadline to apply is coming soon at the end of November, 2022. Here’s how it works: Fill out the screening questionnaire to see if you’re a good fit Week 1: screening week for approved participants (baseline data) Weeks 2 – 3: Consuming the product and sharing your experience with People Science.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.
Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).
This data helps Californians understand the work we have ahead of us in realizing the promises of cannabis legalization, including supporting access to a safe, legal, and equitable cannabis market across the state and combating the unregulated, illicit market”. The data tool can be found on the DCC website here: [link].
What is Coming in 2022? Our NXTecK™ platform is introducing scalable, aggregated, and normalized consumer data with an attribution model, so you know exactly where and how to focus your multi-channel strategies and achieve your digital marketing goals. Free Access to Equio ®. Here’s what they say.
reported a data breach stemming from a misconfigured web application that caused personal information to be accessible on the company’s website. On June 17, 2022, Silverstreak filed an official notice of the breach and sent out data breach letters to all affected parties.
Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. The deadline for proposals is Friday, July 16. The deadline for proposals is Friday, July 16. Between Dec.
million patients in 2022, a sharp increase from the 3.1 This data aligns with Americans’ rising acceptance of cannabis. Policies like telemedicine, curbside pickup, and cannabis delivery made marijuana products more accessible and affordable to countless Americans.
A Flurry of Cannabis M&A Activity in 2022. That is the best way to describe the pace of the cannabis industry in 2022. On the other hand, the international marketplace is far more focused on true medicinal, pharmaceutical development, infrastructure, data, formulations, and the continued development thereof.
So while a cannabis business can join their local chamber of commerce, a patient in hospice can be denied access to medical cannabis. Those who access cannabis through the hemp market or own businesses in hemp are not protected either, as loose definitions of hemp that can be altered in the next Farm Bill reauthorization.
Full commercial product launch in Israel is expected in 2022. Canonic has exclusive access to Evogene’s genomic assets and technology for the development of medical Cannabis products. For more information, please visit: [link]. About Evogene Ltd.:
Reiterates Adjusted EBITDA Profitability Run Rate by December 31, 2022. Reaffirms $150 to $170 Million in Annualized Cost Savings by December 31, 2022. Million in Q4 2022. 20, 2022 /PRNewswire/ – Aurora Cannabis Inc. (the of Aurora’s Q4 2022 consolidated net revenue 1 and 86.3%
DENVER) March 8, 2022 – Simplifya (“Simplifya” or “the Company”), the leading regulatory and operational compliance software platform serving the cannabis industry, announced the launch of its comprehensive suite of compliance solutions in New Mexico, expanding the company’s reach to 24 states. Simplifya Self Audit.
The number of medical cannabis patients in Europe grew by almost 100,000 over the last year, according to new data, but access remains out of reach for many. The majority of people in Europe now live in countries with some form of access to medical cannabis products, says a new report, with approximately 342,000 patients […].
Numerous states in 2021 also enacted legislation expanding medical cannabis access and stimulating greater diversity among licensed marijuana businesses. “As With respect to medical cannabis policies, numerous legislatures took steps in 2021 to expand patients’ access to marijuana products. MEDICAL MARIJUANA ACCESS. California.
The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.” All imaging and behavioral data will be accessible to the public after the study is complete.
A 2022 study of 22 patients with treatment-resistant depression found a 42% reduction in depressive symptoms with ketamine infusions. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” Depression and psychedelics.
While the pool of study subjects could have been larger, researchers were satisfied with the data they gathered from 3,119 respondents. Senators Voted to Broaden Medical Cannabis Access for Veterans . 3,000 Veterans Partook in Survey on CUD . Sponsored by Sen. The amendment seeks to provide doctors in the U.S.
02/28/2022. The survey was designed to better understand who may be interested in accessing psilocybin services, facilitator training program approval, and licensure. The survey was designed to better understand who may be interested in accessing psilocybin services, facilitator training program approval, and licensure.
The subjective nature of self-reported data can plague research. In an August 2022 study published by the Journal of the American Medical Association (JAMA) , psilocybin appears to be an effective tool for reducing problematic alcohol consumption. Always consult a physician before attempting alternative therapies.
Numinus also made important alliances in 2021, particularly with the Multidisciplinary Association for Psychedelic Studies (MAPS) on its compassionate access trial for MDMA-assisted therapy. Also in November, it reported positive data on its standout IND, CYB003. 10 Psychedelic Companies To Watch In 2022.
July 21, 2022 08:00 ET | Source: Metrc LLC. July 21, 2022 (GLOBE NEWSWIRE) — Metrc , the most trusted and experienced provider of cannabis regulatory systems in the U.S., July 21, 2022 (GLOBE NEWSWIRE) — Metrc , the most trusted and experienced provider of cannabis regulatory systems in the U.S., LAKELAND, Fla.,
With the growing acceptance and legalization of cannabis, the pharmaceutical industry is taking serious hits, according to a 2022 novel study into the impact of cannabis legalization on pharmaceutical firms. The team that conducted the study looked at stock return and prescription drug sales data for 556 pharmaceutical companies.
POSTED ON AUGUST 18, 2022. La Jolla, CA: The establishment of licensed cannabis retailers is not independently associated with an increase in traffic crashes, according to data published in the journal Health Economics. In this case, the net effect of expanding access to marijuana on traffic crashes could be quite small.
The disparity and availability study begins 12 months of research that will measure accessibility, whether any discrimination exists, whether it impacts entry and participation, and suggest potential remedies for Illinois cannabis regulation. The finished results of the report will be given to the Illinois General Assembly and Governor.
The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.
On February 28, 2022, the Oregon Psilocybin Services (OPS), a new section within the Oregon Health Authority (OHA), released results from a community interest survey concerning Oregon’s still-developing psilocybin program. The survey opened on January 7, 2022, and closed on February 6, 2022, receiving 4,421 total responses.
Results showed that 58% of respondents were aware of naloxone, but only 35% reported that they would know where to access it in an emergency. In 2022 alone, over 100,000 individuals lost their lives to opioids, a sobering figure that amplifies the necessity of widespread naloxone accessibility and knowledge.
September 27, 2022. On September 22, 2022, Canada’s Minister of Health, Jean-Yves Duclos, and Minister of Mental Health and Addictions and Associate Minister of Health, Carolyn Bennett, announced the overdue legislative review of Canada’s Cannabis Act (Act). By Laura Weinrib , Alexis Levine and Alan Fraser. CANNABIS ACT.
Through the partnership, Maya’s Real World Evidence Platform will be one of the core services offered to the association’s members when it officially launches in Q4 of 2022. NPA’s mission is to ensure all Americans get the support they need to safely access psychedelic-assisted care.
16, 2022 (GLOBE NEWSWIRE) — Metrc , the most trusted and experienced provider of cannabis regulatory systems in the U.S., This marks Metrc’s 23 rd government contract to date and sixth so far in 2022. The State plans to begin accepting licensing applications for businesses on September 1, 2022. “We LAKELAND, Fla.,
Dear MED Stakeholders: The MED is issuing this notice to inform stakeholders of its ongoing efforts to enhance the accessibility of information open to public disclosure. Beginning Monday, August 8, 2022, the MED will begin publishing all Marijuana Business Final Agency Actions on its website. What is a Final Agency Action?
In the further course, however, payments failed to materialize and customer accounts could no longer be accessed. BaFin had previously warned against subordinated loans from Juicy Fields in March 2022. An investor represented by CLLB had invested a total of €13,100 in Juicy Fields between January and July 2022. mobile app.
The budget trailer bill eliminated the cannabis cultivation tax beginning July 1, 2022. The harvested cannabis was first sold or transferred by a cultivator to a distributor on or after July 1, 2022. The harvested cannabis was first sold or transferred by a cultivator to a distributor on or after July 1, 2022. View source.].
25 August 2022. New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. Here’s what they say – nothing that any cannabis user hasn’t know since the 19080’s !
BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. million of interest savings in 2022, and these new term loans will effectively extend the amortization period of the Crown Capital facility, which has a “bullet” maturity in May 2023. About DATA Communications Management Corp. Eastern time.
The Rules will be effective until at least August 19, 2022. The Rules aim to promote social equity, safety and easy access to the cannabis marketplace while keeping local municipalities in control of how they want cannabis businesses to operate in their jurisdiction. –> Scroll to see full table data. Submission Fee.
Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping. Net revenue. Adjusted EBITDA 3.
Before legalization, illicit grow sites did not have access to water utilities and were typically grown in arid/remote areas, often depleting local surface water and shallow aquifers not suited to intensive use. Water resource depletion has been a concern at both outdoor and indoor grow operations. Next Steps.
August 08, 2022 09:30 ET | Source: Allied Market Research. 08, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global hemp clothing market generated $2.29 from 2022 to 2031.The Avenue Basic Plan | Library Access | 1 Year Subscription |. … portland, OR, Aug.
In March, last year the US Food and Drug Administration (FDA) requested specific data on liver toxicity data after saying it believed from CBD use posed ‘real risks’ to human health. Data To Be Used In UK .
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content